Eric Brandt - Dentsply Sirona Non-Executive Independent Chairman of the Board
| DY2 Stock | EUR 17.82 0.10 0.56% |
Chairman
Mr. Eric K. Brandt serves as NonExecutive Independent Chairman of the Board of the Company. Mr. Brandt has served as NonExecutive Chairman of the Board since September 28, 2017. Mr. Brandt has previously served as Senior Vice President and Chief Financial Officer of Broadcom Corporationrationration, a Fortune 500 hightech company, from 2007 to 2009 and then as Executive Vice President and Chief Financial Officer with Broadcom from 2010 to 2016. From September 2005 until March 2007, he served as President and Chief Executive Officer at Avanir Pharmaceuticals. Beginning in 1999, he held various positions at Allergan, Inc., including Corporationrationrate Vice President and Chief Financial Officer until 2001, President of Consumer Eye Care from 2001 to 2002, and 2005 until his departure, Executive Vice President of Finance and Technical Operations and Chief Financial Officer. Prior to joining Allergan, he was Vice President and Partner at Boston Consulting Group, and a senior member of the BCG Health Care and Operations practices. He serves on the Board of Directors for LAM Research Corporation as the Chair, Audit Committee since 2017.
| Age | 57 |
| Tenure | 7 years |
| Phone | 844-848-0137 |
| Web | https://www.dentsplysirona.com |
Eric Brandt Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eric Brandt against Dentsply Sirona stock is an integral part of due diligence when investing in Dentsply Sirona. Eric Brandt insider activity provides valuable insight into whether Dentsply Sirona is net buyers or sellers over its current business cycle. Note, Dentsply Sirona insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dentsply Sirona'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eric Brandt over six months ago Acquisition by Eric Brandt of tradable shares of Dentsply Sirona subject to Rule 16b-3 |
Dentsply Sirona Management Efficiency
The company has return on total asset (ROA) of 0.0345 % which means that it generated a profit of $0.0345 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2157) %, meaning that it generated substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Eric Jacquet | Jacquet Metal Service | 64 | |
Management Performance
| Return On Equity | -0.22 | |||
| Return On Asset | 0.0345 |
Dentsply Sirona Leadership Team
Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Wagner, Chief Officer | ||
| Janet Vergis, Independent Director | ||
| Cheree Johnson, Chief VP | ||
| Lisa Yankie, Senior Vice President Chief Human Resources Officer and Communications | ||
| Francis Lunger, Independent Director | ||
| Jorge Gomez, Chief Financial Officer, Executive Vice President | ||
| Chidam Chidambaram, Senior Vice President Chief Digital Officer | ||
| Andrew Robinson, VP Officer | ||
| Ranjit Chadha, Chief Accounting Officer, Principal Accounting Officer | ||
| Andrea Daley, VP Relations | ||
| Harry Kraemer, Independent Director | ||
| Betsy Holden, Independent Director | ||
| Leslie Varon, Independent Director | ||
| Eric Brandt, Non-Executive Independent Chairman of the Board | ||
| Gregory Lucier, Independent Director | ||
| Donald Casey, Chief Executive Officer, Director | ||
| William Newell, Senior Vice President Chief Segment Officer | ||
| Andreas Frank, Ex Group | ||
| Willie Deese, Independent Director | ||
| Daniel Key, Senior Vice President Chief Supply Chain Officer | ||
| Simon Campion, Pres CEO | ||
| Erania Brackett, VP Officer | ||
| Walter Petersohn, Senior Vice President Chief Commercial Officer | ||
| Matthew Coggin, Senior Vice President Business Development and Strategy Officer | ||
| Keith Ebling, Executive Vice President General Counsel, Secretary | ||
| Michael Alfano, Independent Director | ||
| Clyde Hosein, Director | ||
| Cord Staehler, Senior Vice President, Chief Technology Officer | ||
| Arthur Kowaloff, Independent Director | ||
| Glenn Coleman, Ex CFO |
Dentsply Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.22 | |||
| Return On Asset | 0.0345 | |||
| Profit Margin | (0.24) % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 7.79 B | |||
| Shares Outstanding | 214.91 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 99.40 % | |||
| Price To Earning | 75.67 X | |||
| Price To Book | 1.80 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Dentsply Stock
When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Dentsply Stock please use our How to Invest in Dentsply Sirona guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.